Home›Search›Cancer Innovation

Cancer Innovation

John Wiley and Sons Inc · United States · Est. 1932

ISSN2770-9191eISSN2770-9183

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q2+18

✓ DOAJ Verified+15

Total53

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.538

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Works

246

Total Citations

1,139

2yr Mean Citedness

2.68

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on advancements in cancer treatment and management, particularly emphasizing precision medicine and novel therapeutic strategies. It covers research on targeted therapies, immunotherapies, and the application of technologies like artificial intelligence and advanced imaging in oncology. The scope includes the study of various cancer types such as breast, lung, gastric, colorectal, and hepatocellular carcinoma, exploring their molecular mechanisms, diagnostic approaches, and treatment outcomes.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 50% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1932

StatusActive (last: 2026)

Total Publications246

Publisher OrgWiley

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~12 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2770-9191 / 2770-9183

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ2

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2

OncologyQ3

Pharmacology (medical)Q3

Cancer ResearchQ4

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Drug DiscoveryCancer ResearchOncologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesFerroptosis and cancer prognosisDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and EngineeringHER2/EGFR in Cancer ResearchLung Cancer Research StudiesRadiomics and Machine Learning in Medical ImagingAdvanced Breast Cancer Therapies